Pharmacogenetics Research at SATSU, University of York UK

Pharmacogenetics Research at SATSU

Publications and Reports

Martin P, Lewis G, Smart A, and Webster A (2006) False Positive? The commercial and clinical development of pharmacogenetics (November). Published by SATSU, University of York and IGBiS, University of Nottingham, ISBN No. 978-0-9553542-1-2.

UK Pharmacogenetics Study Group, Policy Issues in Pharmacogenetics: a Policy Briefing from the UK Pharmacogenetics Study Group July 2006.

Hopkins MM, Ibarreta D, Gaisser S, Enzing CM, Ryan J, Martin PA, Lewis G, Detmar S, van den Akker-van Marle ME, Hedgecoe AM, Nightingale P, Dreiling M, Hartig KJ, Vullings W & Forde T., Putting pharmacogenetics into practice Nature Biotechnology 2006, 24(4) 403-410.

Hopkins MM, Lewis GS, Gaisser S, Ryan J, Enzing C, Hartig,J, Vullings W, and Forde T., Regulatory and Quality Assurance Frameworks for PGx: A Comparative Study of the US, EU, and Four EU Member States. Part 3 of the ESTO Study On Pharmacogenetics and Pharmacogenomics: State of the Art and Social and Economic Impacts (April 2006). European Commission/Institute for Prospective Technological Studies, Sevilla, Spain.

Webster A, Martin P, Lewis, G and Smart, A, Integrating pharmacogenetics into society: in search of a model Nature Reviews Genetics, 2004, 5(9) 663-669.

Pirmohamed, M and Lewis G (2004) The Implications of Pharmacogenetics and Pharmacogenomics for Drug Development and Health Care In Regulating Pharmaceuticals in Europe: Striving For Efficiency, Equity and Quality, edited by Elias Mossialos, Monique Mrazek and Tom Walley, Open University Press.

Why Aren't MDs Employing PGx Yet? New Study Aims at Finding Answers SNPTech Reporter, 27 Nov. 2003 ~ on ESRC Science in Society programme project, 'Pharmacogenomics, diagnostic tests, and clinician acceptance' (2004-2006).

Back to... Pharmacogenetics Research at SATSU - Home